No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission

Additional Metadata
Keywords	Acute myeloblastic leukaemia, Bone marrow transplantation, Cytarabine
Persistent URL	doi.org/10.1046/j.1365-2141.2000.02178.x, hdl.handle.net/1765/65905
Journal	British Journal of Haematology
Organisation	Department of Hematology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Cahn, J.-Y., Labopin, M., Sierra, J., Blaise, D., Reiffers, J., Ferrant, A., … Gorin, N.-C. (2000). No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission. British Journal of Haematology, 110(2), 308–314. doi:10.1046/j.1365-2141.2000.02178.x

Publication